| # | Drug | Count |
|---|---|---|
| 0 | RADIUM RA 223 DICHLORIDE | 436 |
| 1 | DOCETAXEL | 196 |
| 2 | DOCETAXEL ANHYDROUS | 196 |
| 3 | ENZALUTAMIDE | 182 |
| 4 | LEUPROLIDE ACETATE | 174 |
| 5 | LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN | 167 |
| 6 | ABIRATERONE ACETATE | 152 |
| 7 | ABIRATERONE | 114 |
| 8 | BICALUTAMIDE | 101 |
| 9 | PREDNISONE | 88 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | RADIUM RA 223 DICHLORIDE | 436 | 0.0863 |
| 1 | CABAZITAXEL | 79 | 0.0225 |
| 2 | FLUTAMIDE | 12 | 0.0121 |
| 3 | LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN | 167 | 0.0121 |
| 4 | BICALUTAMIDE | 101 | 0.0066 |
| 5 | DEGARELIX | 24 | 0.0045 |
| 6 | ABIRATERONE ACETATE | 152 | 0.0037 |
| 7 | ENZALUTAMIDE | 182 | 0.0031 |
| 8 | DOCETAXEL | 196 | 0.0029 |
| 9 | DOCETAXEL ANHYDROUS | 196 | 0.0029 |
| # | Drug class | Count |
|---|---|---|
| 0 | Androgen Receptor Inhibitor [EPC] | 248 |
| 1 | Microtubule Inhibitor [EPC] | 196 |
| 2 | Radioligand Therapeutic Agent [EPC] | 167 |
| 3 | Corticosteroid [EPC] | 131 |
| 4 | RANK Ligand Inhibitor [EPC] | 66 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 41 |
| 6 | Platinum-based Drug [EPC] | 32 |
| 7 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 29 |
| 8 | Loop Diuretic [EPC] | 24 |
| 9 | Xanthine Oxidase Inhibitor [EPC] | 22 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Radioligand Therapeutic Agent [EPC] | 167 | 0.0121 |
| 1 | Androgen Receptor Inhibitor [EPC] | 248 | 0.0034 |
| 2 | Autologous Cellular Immunotherapy [EPC] | 14 | 0.0024 |
| 3 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 29 | 0.0014 |
| 4 | Microtubule Inhibitor [EPC] | 196 | 0.0012 |
| 5 | RANK Ligand Inhibitor [EPC] | 66 | 0.0003 |
| 6 | Blood Viscosity Reducer [EPC] | 1 | 0.0002 |
| 7 | Chloride Channel Activator [EPC] | 2 | 0.0002 |
| 8 | Phosphodiesterase 3 Inhibitor [EPC] | 1 | 0.0002 |
| 9 | Xanthine Oxidase Inhibitor [EPC] | 22 | 0.0001 |